Info

Cougar Biotechnology, Inc. is a development-stage biopharmaceutical company that acquires and develops products for the treatment of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, and then developing those drug candidates for commercial use. It has rights to three clinical stage drug candidates: CB7630 (Abiraterone Acetate), CB3304 (Noscapine and related analogs) and CB1089 (Seocalcitol). It is also conducting pre-clinical development of CB6604, an extended release version of CB3304.(Source: 10KSB)